AUS
NZ
UK
CA
USA
IND
Healthcare
ASX 200 Rallies Into Week’s End as CSL Surges and Uranium Stocks Slide
June 14, 2026 10:56 AM AEST| By SamThe ASX 200 posted strong weekly gains led by CSL and consumer stocks, while uranium and growth shares declined amid sector rotation and shifting macro expectations.
Monash IVF Group ASX 300 Updates Earnings Outlook as Sector Activity Softens
June 12, 2026 11:07 AM AEST| By SamMonash IVF Group updated its earnings outlook amid softer fertility sector activity while expanding market share, strengthening international operations and continuing clinical network development initiatives.
Why OncoSil’s Quiet Update Could Signal a Defining Period Ahead
June 12, 2026 11:05 AM AEST| By SamOncoSil enters a crucial phase as regulatory progress, clinical data, manufacturing expansion, and commercial adoption become the central themes shaping its future.
Why Did Sandfire (ASX:SFR) Shares Record A Sharp Rally Today?
June 12, 2026 02:42 PM AEST| By Sonal GoyalShares of Sandfire Resources Limited (ASX:SFR) were in focus on Friday after advancing more than 8% during the trading session. The stock rose to AUD 19.83, compared with its previous closing price of AUD 18.35, reflecting increased investor participation in the mining company's shares.
Why ASX Healthcare Stocks Are Back Under the Microscope
June 11, 2026 09:46 PM AEST| By SamHealthcare stocks are being reassessed through the diagnostics and devices theme, with readers focusing on business quality, product adoption, operational discipline and the signals influencing sector sentiment.
Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace
June 11, 2026 09:45 PM AEST| By SamHealthcare stocks are being reassessed through valuation repair, with markets focusing on revenue quality, product adoption, margins and execution as companies work to strengthen confidence across the Australian healthcare sector.
From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test
June 11, 2026 09:43 PM AEST| By SamAustralian healthcare stocks are entering a more evidence-driven phase, with attention shifting towards commercial proof, revenue quality, product adoption and operational execution across leading healthcare businesses.
Kalkine ASX Mover: Why did News Corp (ASX:NWS) Fells Today?
June 12, 2026 09:17 AM AEST| By Sonal GoyalNews Corporation Class B Voting CDI (ASX:NWS) traded atAUD 42.30on 12 June 2026, recording a decline of4.26%during the trading session. The movement occurred within a broader environment where media and information services equities remain sensitive to advertising cycles, subscription growth dynamics, and digital transformation …
Why Are These Healthcare Stocks Capturing Market Attention?
June 11, 2026 03:00 PM AEST| By SamSeven healthcare companies spanning biotechnology, diagnostics, hospitals, medical devices, and healthcare software continue drawing attention across Australia's healthcare sector and major market indices.
Which Healthcare Leader Commands More Attention Now?
June 11, 2026 03:00 PM AEST| By SamLeading ASX healthcare companies continue to attract attention through biotechnology, diagnostics, hearing technology and respiratory care, supported by healthcare demand and operational quality.
Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum
June 11, 2026 02:22 PM AEST| By SamCogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets.
Kalkine ASX Update: Australian Oil Company (ASX:AOK) Share Price in Focus – Here’s Why
June 12, 2026 07:26 AM AEST| By Sonal GoyalAustralian Oil Company Limited (ASX:AOK) has provided investors with a comprehensive operational update covering its oil and gas assets in Queensland's Surat Basin. The announcement highlights ongoing production activities, new exploration opportunities, development planning, and commercial negotiations that collectively shape the company's near-term outlook.
Are ASX Healthcare Stocks Rebuilding Strength?
June 11, 2026 02:22 PM AEST| By SamASX healthcare stocks are being reviewed through operational resets, product adoption, hospital activity, diagnostics demand and medical software signals.
Canberra Drone Maker’s ASX Arrival Sparks Fresh Defence Focus
June 11, 2026 09:29 AM AEST| By SamBoresight has entered the ASX as a defence technology company specialising in aerial target drones, with global military customers, expanding manufacturing operations, and a growing role in modern defence training solutions.
ASX Healthcare Innovators 2026: Australia's Global Champions
June 10, 2026 09:55 PM AEST| By SamAustralia's healthcare sector has produced globally recognised leaders through innovation, specialised expertise and international expansion, with CSL, Cochlear, ResMed and Pro Medicus showcasing the country's ability to compete successfully on the w...
Kalkine Share Price Watch: Could Strike Threats Put ASX Mining Giant Under Pressure?
June 12, 2026 04:43 AM AEST| By Sonal GoyalFor a business whose cash flows underpin some of the most popular dividends on the ASX 200, that is a number large enough to move sentiment. The question for shareholders is straightforward but consequential: could a wave of strike threats put Australia’s mining giant …
The Market’s Quiet Achiever: Why Healthcare Keeps Winning
June 10, 2026 09:53 PM AEST| By Vivek SinghHealthcare combines defensive demand with structural growth from ageing populations and medical innovation. From global healthcare leaders to emerging technology specialists, the sector offers resilience and long-term relevance.
Healthcare's Hidden Comeback Story Few Saw Coming
June 10, 2026 09:51 PM AEST| By SamAustralia's leading healthcare companies faced significant pressure from costs, currency movements and market concerns, yet strong industry fundamentals, demographic trends and enduring healthcare demand continue to support the sector's long-term out...
Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build
June 10, 2026 09:41 PM AEST| By SamHighlights,Cogstate attracted strong investor interest as healthcare technology stocks gained momentum on the ASX.,Elevated trading activity highlighted broad market participation in the stock.,The company operates in digital cognitive assessment, su...
ANZ (ASX:ANZ) Leadership Shake-Up: What New Zealand CEO Transition Means for Banking Giant
June 12, 2026 04:43 AM AEST| By Sonal GoyalThe bank has confirmed that the long-serving chief executive of its New Zealand operations will retire, with a successor drawn from within the organisation set to take the reins. Leadership transitions at significant divisions are always closely watched, and this one offers a window …
Singular Health (ASX:SHG) Expands U.S. Reach as 3DICOM Adoption Accelerates
June 10, 2026 04:18 PM AEST| By Aditi SarkarHighlights,Singular Health Group secured a US$500,000 payment after deploying an additional 500 3DICOM MD® licences across the Provider Network Solutions healthcare network.,The company expanded adoption of 3DICOM MD® within clinical workflows, suppo...
Diagnostics Drive Healthcare Stocks ASX 200 Focus
June 10, 2026 01:55 PM AEST| By SamHealthcare stocks are attracting attention as diagnostics, devices, product adoption, reimbursement settings and clinical evidence become key themes across the Australian healthcare sector.
Biotech Commercial Proof Shapes ASX Healthcare ASX 200
June 10, 2026 01:55 PM AEST| By SamASX healthcare stocks are evaluated on commercial proof, revenue momentum, adoption, clinical evidence and operational execution as the sector moves from trial outcomes to validated market performance.
Kalkine Stock Analysis: Is Coles (ASX:COL) Looking Beyond Grocery Playbook
June 12, 2026 04:37 AM AEST| By Sonal GoyalThe inspiration being referenced is the kind of immersive, customer-obsessed approach exemplified by specialty beauty retailing — the “magic” that turns a transaction into an experience and a shopper into a devotee. Applying that philosophy to supermarkets is an intriguing proposition, raising the question …
ASX Healthcare Stocks ASX 200 Valuation Repair Shaping Sector Attention
June 10, 2026 01:54 PM AEST| By SamASX healthcare stocks are assessed through valuation repair, revenue momentum, product adoption, clinical evidence, margin quality, and operational execution across CSL, ResMed, Cochlear, Pro Medicus, and Telix Pharmaceuticals.
Why Is Telix Pharmaceuticals Drawing Attention Within the ASX 200 Healthcare Space?
June 10, 2026 10:04 AM AEST| By SamTelix Pharmaceuticals remains a healthcare stock to watch as clinical development, commercial growth and strategic partnerships continue driving attention.
Advertise your brand on Kalkine Media